Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: Thermoregulatory and locomotor effects

Psychopharmacology

Volumn 197, Issue 1, 2008, Pages 67-82

  Hamida, Sami Ben ^a   Plute, Erin ^a   Cosquer, Brigitte ^a   Kelche, Christian ^a   Jones, Byron C ^b   Cassel, Jean Christophe ^a  

^a Université Louis Pasteur   (France)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Abuse; Alcohol; Amphetamine; Cocaine; Locomotor activity; Rat; Temperature

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; COCAINE; PSYCHOSTIMULANT AGENT; SEROTONIN;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CHEMICAL INTERACTION; CONTROLLED STUDY; DOSE RESPONSE; HYPERACTIVITY; HYPERTHERMIA; HYPOTHERMIA; LOCOMOTION; MALE; MULTIPLE DRUG ABUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; THERMOREGULATION;

AMPHETAMINE; ANIMALS; BODY TEMPERATURE REGULATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DRUG INTERACTIONS; ETHANOL; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, LONG-EVANS;

EID: 40949127474     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-1007-5     Document Type: Article

References (88)

1. Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320
2. Ansah TA, Wade LH, Shockley DC (1996) Changes in locomotor activity, core temperature, and heart rate in response to repeated cocaine administration. Physiol Behav 60:1261-1267
3. Antoniou K, Kafetzopoulos E, Papadopoulou-Daifoti Z, Hyphantis T, Marselos M (1998) D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 23:189-196
4. Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26:40-52
5. Barrett SP, Darredeau C, Pihl RO (2006) Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol 21:255-263
6. Bast T, Pezze MA, Feldon J (2002) Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition. Behav Pharmacol 13:669-673
7. Ben Hamida S, Bach S, Plute E, Jones BC, Kelche C, Cassel JC (2006) Ethanol-ecstasy (MDMA) interactions in rats: preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment. Pharmacol Biochem Behav 84:162-168
8. Ben Hamida S, Plute E, Bach S, Lazarus C, Tracqui A, Kelche C, de Vasconcelos AP, Jones BC, Cassel JC (2007) Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination. Psychopharmacology (Berl) 192:555-569
9. Beveridge TJ, Mechan AO, Sprakes M, Pei Q, Zetterstrom TS, Green AR, Elliott JM (2004) Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. Psychopharmacology (Berl) 173:346-352
10. Bexis S, Docherty JR (2005) Role of alpha2A-adrenoceptors in the effects of MDMA on body temperature in the mouse. Br J Pharmacol 146:1-6
11. Bexis S, Docherty JR (2006) Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors. Br J Pharmacol 147:926-934
12. Bexis S, Phillis BD, Ong J, White JM, Irvine RJ (2004) Baclofen prevents MDMA-induced rise in core body temperature in rats. Drug Alcohol Depend 74:89-96
13. Borbely AA, Baumann IR, Waser PG (1974) Amphetamine and thermoregulation: studies in the unrestrained and curarized rat. Naunyn Schmiedebergs Arch Pharmacol 281:327-340
14. Brennan KA, Schenk S (2006) Initial deficit and recovery of function after MDMA preexposure in rats. Psychopharmacology (Berl) 184:239-246
15. Bubar MJ, Pack KM, Frankel PS, Cunningham KA (2004) Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. Psychopharmacology (Berl) 173:326-336
16. Bunney EB, Appel SB, Brodie MS (2000) Cocaine potentiates ethanol-induced excitation of dopaminergic reward neurons in the ventral tegmental area. J Pharmacol Exp Ther 293:383-389
17. Bunney EB, Appel SB, Brodie MS (2001) Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther 297:696-703
18. Callaway CW, Clark RF (1994) Hyperthermia in psychostimulant overdose. Ann Emerg Med 24:68-76
19. Cassel JC, Jeltsch H, Koenig J, Jones BC (2004) Locomotor and pyretic effects of MDMA-ethanol associations in rats. Alcohol 34:285-289
20. Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R (2005) Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology 30:1870-1882
21. Cassel JC, Hamida SB, Jones BC (2007) Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature. Eur J Pharmacol 571:152-155
22. Colado MI, Granados R, O'shea E, Esteban B, Green AR (1998) Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. Br J Pharmacol 124:479-484
23. Colado MI, O'shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173:249-263
24. Cole JC, Sumnall HR (2003) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 27:199-217
25. Cole JC, Sumnall HR, Smith GW, Rostami-Hodjegan A (2005) Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs. J Psychopharmacol 19:67-70
26. Crandall CG, Vongpatanasin W, Victor RG (2002) Mechanism of cocaine-induced hyperthermia in humans. Ann Intern Med 136:785-791
27. Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA (2006) Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4- methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience 142:515-525
28. Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berl) 114:505-508
29. Duncan PM, Cook NJ (1981) Ethanol-amphetamine interaction effects on spontaneous motor activity and fixed-interval responding. Psychopharmacology (Berl) 74:256-259
30. Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194-210
31. Fletcher PJ, Korth KM, Robinson SR, Baker GB (2002) Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) 162:282-291
32. Fletcher PJ, Sinyard J, Higgins GA (2006) The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) 187:515-525
33. Geyer MA (1996) Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31-35
34. Gold LH, Hubner CB, Koob GF (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology (Berl) 99:40-47
35. Goni-Allo B, Ramos M, Herv'as I, Lasheras B, Aguirre N (2006) Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/malonate combination: implications for serotonin/dopamine interactions. J Psychopharmacol 20:245-256
36. Gonzalez LP (1993) Cocaine alters body temperature and behavioral thermoregulatory responses. Neuroreport 4:106-108
37. Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berl) 119:247-260
38. Green AR, Mechan AO, Elliott JM, O'shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
39. Green AR, O'shea E, Colado MI (2004a) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500:3-13
40. Green AR, Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI (2004b) Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology (Berl) 173:264-269
41. Green AR, O'shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
42. Han DD, Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6
43. Hedaya MA, Pan WJ (1996) Cocaine and alcohol interactions in naive and alcohol-pretreated rats. Drug Metab Dispos 24:807-812
44. Hedaya MA, Pan WJ (1997) Effect of alcohol coadministration on the plasma and brain concentrations of cocaine in rats. Drug Metab Dispos 25:647-650
45. Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA (2005) Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl) 178:505-513
46. Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de la TR (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236-244
47. Hoplight BJ, Vincow ES, Neumaier JF (2005) The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task. Physiol Behav 84:707-714
48. Izco M, Orio L, O'shea E, Colado MI (2007) Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology (Berl) 189:459-470
49. Jackson DM, Johansson C, Lindgren LM, Bengtsson A (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol Biochem Behav 48:465-471
50. Jaehne EJ, Salem A, Irvine RJ (2005) Effects of 3,4- methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation. Pharmacol Biochem Behav 81:485-496
51. Johnson EA, O'Callaghan JP, Miller DB (2004) Brain concentrations of d-MDMA are increased after stress. Psychopharmacology (Berl) 173:278-286
52. Jones BC, Cassel JC (2007) Ethanol and MDMA: a comment on the paper by Izco et al. Psychopharmacology (Berl) 191:387-388
53. Kankaanpaa A, Meririnne E, Lillsunde P, Seppala T (1998) The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav 59:1003-1009
54. Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996) Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116-124
55. Kita K, Shiratani T, Takenouchi K, Fukuzako H, Takigawa M (1999) Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats. Eur Neuropsychopharmacol 9:1-7
56. Kostowski W, Plaznik A, Pucilowski O, Malatynska E (1982) Effect of lesions of the brain noradrenergic systems on amphetamine-induced hyperthermia and locomotor stimulation. Acta Physiol Pol 33:383-387
57. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J (2001) Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus accumbens. Brain Res 915:176-184
58. Lomax P, Daniel KA (1990) Cocaine and body temperature in the rat: effects of ambient temperature. Pharmacology 40:103-109
59. Lora-Tamayo C, Tena T, Rodriguez A, Moreno D, Sancho JR, Ensenat P, Muela F (2004) The designer drug situation in Ibiza. Forensic Sci Int 140:195-206
60. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) 144:67-76
61. Masur J, Souza-Formigoni ML, Pires ML (1989) Increased stimulatory effect by the combined administration of cocaine and alcohol in mice. Alcohol 6:181-182
62. McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine (1A) and 5-hydroxytryptamine (1B/1D) receptors. J Pharmacol Exp Ther 290:965-973
63. McMahon LR, Cunningham KA (2001) Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363
64. Mechan AO, Esteban B, O'shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
65. Moser PC, Moran PM, Frank RA, Kehne JH (1996) Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behav Brain Res 73:163-167
66. Neumaier JF, Vincow ES, Arvanitogiannis A, Wise RA, Carlezon WA Jr (2002) Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. J Neurosci 22:10856-10863
67. O'Neill MF, Shaw G (1999) Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl) 145:237-250
68. O'shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926
69. Pan WJ, Hedaya MA (1999a) Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J Pharm Sci 88:468-476
70. Pan WJ, Hedaya MA (1999b) Cocaine and alcohol interactions in the rat: effect of cocaine and alcohol pretreatments on cocaine pharmacokinetics and pharmacodynamics. J Pharm Sci 88:1266-1274
71. Pan WJ, Hedaya MA (1999c) Cocaine and alcohol interactions in the rat: effect on cocaine pharmacokinetics and pharmacodynamics. J Pharm Sci 88:459-467
72. Pedersen W, Skrondal A (1999) Ecstasy and new patterns of drug use: a normal population study. Addiction 94:1695-1706
73. Przegalinski E, Filip M, Papla I, Czepiel K (2002) Effects of 5-HT1B receptor ligands microinjected into the accumbal shell or core on the cocaine-induced locomotor hyperactivity in rats. J Physiol Pharmacol 53:383-394
74. Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA (2006) Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 31:2349-2358
75. Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23-40
76. Saadat KS, O'shea E, Colado MI, Elliott JM, Green AR (2005) The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. Psychopharmacology (Berl) 179:884-890
77. Scearce-Levie K, Viswanathan SS, Hen R (1999) Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology (Berl) 141:154-161
78. Schifano F (2004) A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl) 173:242-248
79. Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2004) Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav 29:743-752
80. Shankaran M, Gudelsky GA (1999) A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology (Berl) 147:66-72
81. Steketee JD, Braswell BC (1997) Injection of SCH 23390, but not 7-hydroxy-DPAT, into the ventral tegmental area blocks the acute motor-stimulant response to cocaine. Behav Pharmacol 8:58-64
82. Taffe MA, Weed MR, Davis S, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH (2001) Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology 24:230-239
83. Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN (2006) Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. Drug Alcohol Depend 82:276-281
84. Uhl GR, Lin Z (2003) The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions. Eur J Pharmacol 479:71-82
85. Ulus IH, Kiran BK, Ozkurt S (1975) Involvement of central dopamine in the hyperthermia in rats produced by d-amphetamine. Pharmacology 13:309-316
86. Vanderschuren LJ, Beemster P, Schoffelmeer AN (2003) On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169:176-185
87. Winer BJ (1971) Statistical Principles in Experimental Design. McGraw-Hill: New York.
88. Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G (2006) Loss of Serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31:2639-2651